- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01220674
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
September 12, 2023 updated by: University of Nebraska
A computer-based neuropsychological assessment tool is being developed to help primary care physicians detect neurological and psychiatric disorders.
The first version will be tested against current tests to confirm the tool's effectiveness.
Data will be collected on how well the tool detects disease, how well patients understand the instructions and enjoy performing the tasks, and if particular trials or stimuli are too difficult or too easy for all subjects.
Adjustments can then be made to the assessment tool, if needed.
The initial participants will be age fifty-five to seventy-five with early dementias or mild cognitive impairment to reduce variability.
Study Overview
Detailed Description
The investigators are developing a computer-based neuropsychological assessment tool to help primary care physicians detect neurological and psychiatric disorders.
To confirm the tool's efficacy, the investigators will first test the prototype against established tests.
The investigators propose to collect preliminary data on a limited group of subjects and age-matched controls.
Collecting data on a limited group of subjects provides early insight into how well the tool detects disease, how well patients understand the instructions and enjoy performing the tasks, and if particular trials or stimuli are too difficult or too easy for all subjects.
With this information, the investigators can make adjustments to the tool if needed and collect additional data on revised versions of the tool.
The data will be used to establish the validity, reliability and sensitivity of the tool to generate consistent and accurate scores.
The investigators will initially focus on a limited age range (age fifty-five to seventy-five) and limited set of diseases (early dementias or mild cognitive impairment) to reduce variability within the patient and control groups and to gain more statistical power with a smaller group of subjects.
Study Type
Observational
Enrollment (Actual)
152
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198
- Unversity of Nebraska Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Community-dwelling adults without significant cognitive impairment
Description
Inclusion Criteria:
- Any subject with mild impairment from who has already undergone or will soon undergo a full neuropsychological evaluation.
- Subjects with Clinical Dementia Rating Scale CDR of 0.5-1.0 and Mini-Mental Score 20-26 (or MOCA equivalent, borderline/mild dementia) will be eligible for this group.
- Normal controls without exclusion criteria.
Exclusion Criteria:
- Subjects whose impairment is severe enough to limit their ability to perform the computer-based tasks and/or to provide consent.
- Subjects with history of learning disabilities or mental illness including major depression, bipolar disorder, anxiety disorders, and addiction are excluded because these problems can affect cognitive performance.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
community dwelling older adults, normal controls
men and women 55 years of age or older who are cognitively intact.
|
computer-based cognitive assessment
|
community dwelling older adults, mild cognitive impairment
men and women 55 years of age or older who have minimal cognitive decline (MMSE 20-24).
|
computer-based cognitive assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephen J Bonasera, MD, PhD, University of Nebraska
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2010
Primary Completion (Actual)
October 31, 2012
Study Completion (Actual)
October 31, 2012
Study Registration Dates
First Submitted
October 12, 2010
First Submitted That Met QC Criteria
October 13, 2010
First Posted (Estimated)
October 14, 2010
Study Record Updates
Last Update Posted (Actual)
September 14, 2023
Last Update Submitted That Met QC Criteria
September 12, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0491-10-FB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaNot yet recruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive Impairment
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University Health Network, TorontoRecruiting
-
Wake Forest University Health SciencesActive, not recruiting
Clinical Trials on cognitive testing
-
University of California, Los AngelesDanone Nutricia ResearchCompleted
-
Dr. Stephen ChoiActive, not recruitingAutoimmune Diseases | Inflammation | Delirium | Cognitive Impairment | Cognitive Change | Postoperative Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive Decline | Working MemoryCanada
-
University of ZurichEnrolling by invitation
-
Region ÖstergötlandRecruitingCognitive Symptom | Primary Health Care | Mental Health IssueSweden
-
University of UtahEnrolling by invitationDementia | Hearing Loss | Presbycusis
-
University of AarhusCompletedRadiation Toxicity | Primary Brain TumorDenmark
-
Dr. Stephen ChoiCompletedDelirium | Cognitive Change | Postoperative Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive Deficit | Working Memory
-
Barcelonabeta Brain Research Center, Pasqual Maragall...Enrolling by invitation
-
University of FloridaNational Institute on Aging (NIA); National Center for Advancing Translational...RecruitingCognitive DysfunctionUnited States
-
Istituto Ortopedico GaleazziUnknown